| |
| Date Posted |
Description |
Download |
| |
| 1/19/2010 |
The North American Thrombosis Forum (NATF)* Honors... |
NATF release-1-12-10.pdf |
| |
| 1/6/2010 |
Eisai Completes Acquisition of AkaRx, Inc. and Con... |
Eisai Completes Acqusition of AkaRx - 1-06-10F.pdf |
| |
| 12/22/2009 |
Results From Phase II Trial in Critical Care Me... |
Study 201 in CCM press release LMR APPROVED CLEAN 12.18.09.pdf |
| |
| 11/24/2009 |
FDA Accepts Once Daily 23 mg Aricept® E... |
Aricept 23 Filing Acceptance Press Release 11-24-09.pdf |
| |
| 11/16/2009 |
LUSEDRA™ (fospropofol disodium) Injection CIV for ... |
Lusedra Injection CIV 111609.pdf |
| |
| 11/10/2009 |
Eisai Launches New Educational Program for Caregiv... |
LGS NTS press release 11 05 09 final clean.pdf |
| |
| 10/30/2009 |
Global Phase III Study Results Show Eribulin Meets... |
Eribulin Study 305 US Press Release 10.30.09.pdf |
| |
| 10/29/2009 |
C.A.R.E. Pharmacy Award Release |
CARE Pharmacy Award - FINAL.pdf |
| |
| 10/28/2009 |
Morphotek-Centor Ortho Biotech Licensing Deal |
Morphotek Centocor Press Release FINAL.pdf |
| |
| 9/25/2009 |
Eisai Announces Agreement with Pfizer on Strategic... |
Aricept Pf (E) 092509FINALclean.pdf |
| |
| 9/24/2009 |
Farletuzumab Data Presented on Phase II Clinical T... |
FINAL_ESMO.Farletuzumab_Ph2_PressRelease_US.09.24.09.pdf |
| |
| 9/23/2009 |
Morphotek®, Inc. Awarded Funding to Develop Therap... |
Morphotek NIAID Funding Press Release with IP, LMR, ECL, NIAID's comments 9.17 CLEAN.pdf |
| |
| 7/15/2009 |
Morphotek®, Inc. and Cancer Innovations... |
Cancer Innovations - Morphotek Press Release 7.13.09 CLEAN and FINAL.pdf |
| |
| 7/8/2009 |
FDA Accepts sNDA for Alternative Dosing Regimen fo... |
sNDA Press Release FINAL 7 08 09.pdf |
| |
| 7/1/2009 |
Morphotek®, Inc. Announces a Research C... |
Morphotek-Synageva release 6 23 09 Draft with LMR edits CLEAN.pdf |
| |
| 6/9/2009 |
Morphotek®, Inc. Announces FDA Acceptan... |
MORAb-004 IND Press Release - FINAL.pdf |
| |
| 6/1/2009 |
Call for Nominations for the 2009 C.A.R.E. Pharmac... |
CARE Pharmacy Award - FINAL.pdf |
| |
| 5/19/2009 |
Morphotek®,Inc. and Lonza Group Ltd Enter into Man... |
Lonza Morphotek Press Release - FINAL.pdf |
| |
| 5/12/2009 |
Experts Urge Family Members and Friends to Seek Im... |
ADSDG Press Release_050709.pdf |
| |
| 5/4/2009 |
New Survey Reveals Gap in Understanding of Alzheim... |
2A Eisai CBC Press Release.pdf |
| |
| 4/27/2009 |
Eisai Senior Health Digest Offers Insights into Me... |
SHD AMCP Release 4 27 09 FINAL.pdf |
| |
| 3/25/2009 |
Human Genome Sciences and Morphotek®, I... |
HGS Morphotek Joint Release - FINAL.pdf |
| |
| 3/23/2009 |
Morphotek® , Inc. and Eisai Corporation... |
morphotek spa release 032309.pdf |
| |
| 3/2/2009 |
MORPHOTEK®, INC. ANNOUNCES INITIATION O... |
Revised 009 Phase II trial in mesothelioma release - FINAL.pdf |
| |
| 1/14/2009 |
Morphotek®, Inc. Announces Evaluation A... |
Morphotek Univ of Heidelberg Press Release 10.13 6pm FINAL CLEAN.pdf |
| |
| 12/18/2008 |
Morphotek University of PA Press Release FINAL |
Morphotek University of PA Press Release FINAL Clean.pdf |
| |
| 12/14/2008 |
FDA Approves LUSEDRA™ (fospropofol disodium) Injec... |
Approval release 12.12.08 FINAL.pdf |
| |
| 12/9/2008 |
Dacogen® (decitabine for injection) Dat... |
AML Release FINAL FLAT 12.2 - Clean.pdf |
| |
| 12/9/2008 |
DVTeamCare Award |
DVTeamCare Award FINAL.pdf |
| |
| 12/2/2008 |
Morphotek®, Inc. Announces Initiation of Farletuzu... |
Initiation of Phase II Ovarian Cancer Study - FINAL.pdf |
| |
| 12/2/2008 |
DAC200-H2H Press Release |
DAC200 - H2H Press Release 11.29.08 FINAL.pdf |
| |
| 11/25/2008 |
CARE Pharmacy Award Recipient 2008 |
CARE Pharmacy Award Recipient 2008 - 11-21-08 Final.pdf |
| |
| 11/14/2008 |
LGS approval |
Press Release - LGS approval.pdf |
| |
| 10/15/2008 |
FDA Grants Full Approval to ONTAK® (denileukin dif... |
ONTAK final press release 101508.pdf |
| |
| 9/25/2008 |
Morphotek®, Inc. and Pivotal BioScience... |
Morphotek Pivotal BioSciences Final Release 9.17.pdf |
| |
| 9/24/2008 |
New Alzheimer's Disease Survey Reveals Dispari... |
Alzheimer's Disease Survey Press Release_FINAL.pdf |
| |
| 9/15/2008 |
Eisai Inc. Supports Acting Surgeon General's C... |
Eisai_Supports_SG_press_release_9-15-08_Approved[1].pdf |
| |
| 8/26/2008 |
MORPHOTEK®, INC. EXPANDS ITS PHASE II T... |
MORAb-009 Expands Phase II Trial in EU - FINAL.pdf |
| |
| 8/23/2008 |
FDA Approves ALOXI® (Palonosetron HCl) Capsules fo... |
Aloxi capsule CINV action date release 082308.pdf |
| |
| 8/13/2008 |
MORPHOTEK®, INC. ANNOUNCES LICENSE AGR... |
NCI Press Release - FINAL.pdf |
| |
| 7/25/2008 |
Eisai Receives Action Letter on Fospropofol Disodi... |
Fospropofol Not Approvable Release 07.25.08 FINAL.pdf |
| |
| 7/24/2008 |
Morphotek Executive, Rodney Dausch, Named Small Co... |
Dausch CFO of the year - FINAL.pdf |
| |
| 7/21/2008 |
U.S. FEDERAL CIRCUIT COURT OF APPEALS FULLY UPHOLD... |
Aciphex ANDA Appeal Decision - Final.pdf |
| |
| 7/10/2008 |
Eisai Renews its Commitment to Responsible Healthc... |
Press Release - Revised PhRMA Marketing Code.pdf |
| |
| 7/8/2008 |
ALOXI® (PALONOSETRON HCL) INJECTION AVA... |
FINAL Aloxi PONV US version 7-8-08 e.pdf |
| |
| 7/1/2008 |
EISAI PROVIDES PRELIMINARY EFFICACY UPDATE ON EORT... |
EORTC Release 07 01 08 PM FINAL.pdf |
| |
| 6/30/2008 |
FDA Approves ACIPHEX® (rabeprazole sodi... |
AcipHex Adolescent app release FINAL 6-30-08 e.pdf |
| |
| 6/26/2008 |
FDA Files Application to Convert ONTAK®... |
sBLA filing release FINAL.pdf |
| |
| 6/17/2008 |
Morphotek®, Inc. Receives $1.7M in Fund... |
Draft DOD 1.7M Funding press release - FINAL.pdf |
| |
| 5/19/2008 |
MORPHOTEK® ANNOUNCES COLLABORATION TO F... |
FINAL Clean CRADA Announcement 5.19.pdf |
| |
| 5/15/2008 |
Eribulin Mesylate Demonstrated Anti-tumor Activity... |
211 Release ASCO 05.15.08 FINAL.pdf |
| |
| 5/15/2008 |
Eisai's Commitment to Oncology Demonstrated by... |
Pre-ASCO Release 5.28.08 CLEAN U.S..pdf |
| |
| 5/7/2008 |
FDA Advisory Committee Votes in Favor of Approval ... |
ALSDAC Press Release 050708.pdf |
| |
| 5/5/2008 |
Eisai Corporation of North America Announces Appoi... |
Schwalm release draft - Final.pdf |
| |
| 4/16/2008 |
EUROPEAN REGULATORY AGENCY GRANTS ORPHAN STATUS TO... |
EMEA M3 and M9 Orphan Status - FINAL CLEAN.pdf |
| |
| 3/28/2008 |
Press Release: Eisai Is Granted Favorable Prelimin... |
Eisai Granted Preliminary Injunction - Aricept.pdf |
| |
| 3/2/2008 |
FDA Approves Aloxi® Injection for Preve... |
Aloxi action date US FINAL 03.02.08 CLEAN.pdf |
| |
| 2/29/2008 |
FDA Grants Priority Review for ACIPHEX®... |
Adolescent sNDA.acceptance press release.FINAL_e.pdf |
| |
| 2/1/2008 |
E7389 Submission Schedule Change ECL US Release |
E7389 Submission Schedule Change ECL U S Release FINAL Formatted 02 01 08 (6).pdf |
| |
| 1/28/2008 |
EISAI COMPLETES ACQUISITION OF MGI PHARMA
|
Eisai Completes Acquisition of MGI PHARMA 012808F.pdf |
| |
| 1/26/2008 |
Completion of Tender Offer For MGI PHARMA Shares |
TO Complete 1-26-08 FINAL.pdf |
| |
| 1/23/2008 |
Eisai Tender Offer Expiration Release |
Eisai Tender Offer Expiration Release.pdf |
| |
| 1/17/2008 |
Early Termination of HSR Waiting Period for Eisai&... |
MGI acquisition bid - HSR clearance press release.pdf |
| |
| 12/27/2007 |
Mutual Press Release |
Mutual Press Release FINAL 12.27.07.pdf |
| |
| 12/21/2007 |
Tender Offer Press Release |
Tender Offer Press Release 122107.pdf |
| |
| 12/10/2007 |
Press release -- Eisai to acquire MGI PHARMA |
Press Release -- Eisai to Acquire MGI PHARMA.pdf |
| |
| 5/7/2007 |
FDA Approves New Indication for FRAGMIN® |
FRAGMIN New Indication Press Release 5.02.07A Clean.pdf |
| |
| |
 Printer Friendly Version
|
